InspireMD (NSPR) Shareholder's Equity Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.96% |
| Sep 30, 2025 | 43.12% |
| Jun 30, 2025 | -7.70% |
| Mar 31, 2025 | -1.55% |
| Dec 31, 2024 | 2.48% |
| Sep 30, 2024 | 3.72% |
| Jun 30, 2024 | 4.63% |
| Mar 31, 2024 | -7.24% |
| Dec 31, 2023 | 48.09% |
| Sep 30, 2023 | 56.52% |
| Jun 30, 2023 | 52.44% |
| Mar 31, 2023 | 56.88% |
| Dec 31, 2022 | 47.84% |
| Sep 30, 2022 | 40.44% |
| Jun 30, 2022 | 66.53% |
| Mar 31, 2022 | 73.99% |
| Dec 31, 2021 | 56.41% |
| Sep 30, 2021 | 50.14% |
| Jun 30, 2021 | 115.18% |
| Mar 31, 2021 | 247.88% |
| Dec 31, 2020 | 64.61% |
| Sep 30, 2020 | 43.97% |
| Jun 30, 2020 | 32.03% |
| Mar 31, 2020 | -23.33% |
| Dec 31, 2019 | 9.99% |
| Sep 30, 2019 | 8.23% |
| Jun 30, 2019 | 45.72% |
| Dec 31, 2018 | 70.71% |
| Jun 30, 2018 | 19.92% |
| Dec 31, 2017 | 43.88% |
| Jun 30, 2017 | 59.44% |
| Mar 31, 2017 | 28.77% |
| Dec 31, 2016 | -22.35% |
| Sep 30, 2016 | -21.77% |
| Jun 30, 2016 | -32.31% |
| Dec 31, 2015 | -154.28% |
| Jun 30, 2015 | -23.88% |
| Dec 31, 2014 | -34.12% |
| Jun 30, 2014 | -33.71% |
| Dec 31, 2013 | 125.40% |
| Sep 30, 2013 | 216.71% |
| Jun 30, 2013 | 199.58% |